Eye :: UF researchers awaken vision cells in blind mice
University of Florida researchers used gene therapy to restore sight in mice with a form of hereditary blindness, a finding that has bearing on many of the most common blinding diseases.
Professor
Bone :: FSU engineering professor growing bone in a lab
As the nation ages, an estimated 44 million Americans, including at least half of those ages 50 and older, are at risk for osteoporosis, making their bones fragile and vulnerable to serious fractures.
Skin Cancer :: Gene expression profiling in mice can predict risk of skin lesions progressing to cancer
A new study has shown that microarray technology, which allows researchers to simultaneously compare the degree to which hundreds of genes are expressed (converted into proteins), now makes it possible to more definitively identify skin lesions in mice that are thought to be at high risk of progressing to a type of cancer known as squamous cell carcinoma (SCC).
Hypertension :: To get blood pressure under control, combination of medicines may be best
Millions of Americans take medications for hypertension but do not achieve control of their blood pressure. Single-tablet combinations of drugs may be what it takes to get blood pressure under control, even in people with moderate hypertension, according to results from a new international study involving more than 10,700 people with high blood pressure.
Osteosarcoma :: U of MN will lead national research study on causes of bone cancer in children
Logan Spector, Ph.D., a University of Minnesota Cancer Center researcher, has received a $1.7 million grant from the National Cancer Institute (NCI) to lead the largest and most comprehensive study to date on the causes of pediatric osteosarcoma.
Breathing :: Wake Up and Breathe Strategy allows patients to come off ventilator sooner
A new study of intensive care unit patients who are breathing with the help of a mechanical ventilator has found that a two-step sedation and ventilator weaning protocol?called a ?wake up and breathe? strategy?helps patients come off the ventilator faster so that they can be discharged from the ICU and hospital more quickly.
COPD :: Perforomist inhalation solution effective for COPD, emphysema, chronic bronchitis
Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist? (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).
Economy :: Securing a Financial Future
Despite economic hardships, low-income women can build wealth. Extensive interviews with participants in an asset-building program offer new insight into how and why women go about securing their financial future.
Prostate Cancer :: Veterans exposed to Agent Orange have higher rates of prostate cancer recurrence
Veterans exposed to Agent Orange have a 48 percent increased risk of prostate cancer recurrence following surgery than their unexposed peers, and when the disease comes back, it seems more aggressive, researchers say.
Heart Attack :: Sanofi’s Lovenox for heart attack approved by FDA
Sanofi-aventis (SNY) announced that the Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the anticoagulant Lovenox(R) (enoxaparin sodium injection) for the treatment of patients with acute ST-segment elevation myocardial infarction (STEMI).